Hemostats Market Research Report – Forecast to 2027

Hemostats Market: Product Type (Thrombin Based, Collagen Based, Tissue Sealants- Fibrin Sealants, and Others), Instrument Type (Halstead Mosquito Hemostatic Forceps,), Application (Gynecology, Neurology, Cardiovascular) - Forecast Till 2027

ID: MRFR/MED/4952-HCR | October 2022 | Region: Global | 100 Pages         

Hemostats Market

Hemostats are surgical instruments used to keep a patient's bleeding under control during surgery.

Segmentation

By Product Type Thrombin Based Collagen Based Tissue Sealants Fibrin Sealants Others
By Instrument Type Halstead Mosquito Hemostatic Forceps
By Application Gynecology Neurology Cardiovascular

Key Players

  • CR Bard
  • Inc. (US)
  • B. Braun Melsungen AG (Germany)
  • Baxter International Inc. (US)
  • Integra LifeSciences (US)
  • Marine Polymer Technologies Inc. (US)
  • Teleflex (US)
  • Ethicon Inc. (US)
  • Pfizer Inc. (US)
  • Z-Medica LLC (US)
  • Gelita Medical GmbH

Drivers

  • Growing number of surgical procedures
  • Continuous progression in products range
  • Rising incidences of sports-related damages
  • Spinal disorders
Speak to Analyst Request a Free Sample

Hemostats Market Overview
 
Hemostats market is estimated to grow at a CAGR of 6.4 percent during the forecast period. Hemostats are surgical tools that control bleeding in a patient after surgery. The rising prevalence of sports-related injuries and spinal problems, as well as the expanding focus on effective blood loss control in patients during surgeries, are driving expansion in this market. Hemostats, on the other hand, are expected to stall uptake due to their negative consequences and allergic reactions. The most important driving force in the global market is the rise in the number of surgical procedures performed globally, which has fueled the rise in the incidence of post-surgery bleeding.
 
A wide range of medical devices are currently available for management, and significant progress has been achieved in achieving hemostasis during surgical procedures. In today's healthcare environment, chronic diseases such as cardiovascular disease, cancer, and cases of trauma and accidents are on the rise. The market will continue to grow as the number of medical facilities responding to patients' surgical needs continues to rise. As a result, there is a growing and continuing demand for a varied range of effective product offerings for treating bleeding difficulties in a variety of surgical procedures.

Segmentation


The hemostats market has been segmented on the basis of product type, instrument type, application, and end-user.


On the basis of product type, the market has been classified as thrombin-based, combination based, oxidized regenerated cellulose-based, gelatin based, collagen-based hemostat, tissue sealants, cyanoacrylate-based tissue adhesives, adhesion prevention products. The tissue sealants have been segmented into fibrin sealants, protein-based sealants.


On the basis of instrument type, the market has been classified as halstead mosquito hemostatic forceps, kelly and crile hemostatic forceps, and rochester-carmalt hemostatic forceps.


On the basis of application, the market has been classified as cardiovascular surgery, general surgery, gynecological surgery, reconstructive surgery, neurological surgery, orthopedic surgery, and other surgeries.


On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, community healthcare, and others.


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European hemostats market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The hemostats market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hemostats market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Hemostats Market Share, by Region, 2017 (%)


Hemostats Market Share


Source: MRFR Analysis


In the hemostats market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. According to the National Health Statistics Report by the Centers of Disease Control & Prevention, in 2014, about 201,748.3 million surgical procedures were carried out in the U.S. The statistics also showed that 28.6 million appointments to ambulatory surgery cases were informed in the U.S.


The European market is expected to hold the second largest market share. The market growth in this region can be attributed to growing frequency of cardiovascular disorders, increasing number of surgeries and rising demand for advanced treatment procedures are boosting the European market.


The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.


The market in the Middle East and Africa is expected to account for the smallest share of the global hemostats market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global hemostats market are CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).

Recent Development


In 2022 March, To extend sales potential for the AC5 Advanced Wound System, Arch Therapeutics, a developer of revolutionary self-assembling wound care and surgical devices, has announced a distribution agreement with Centurion Therapeutics Inc., the world's leading tissue bank's exclusive strategic partner. Centurion offers a comprehensive range of aseptically processed human tissues to surgeons in a variety of fields through over a hundred contracted wound care distributors around the country.
 
Teleflex expanded its product portfolio in 2020 by acquiring Z-Medica, LLC (US), a privately held medical device firm that manufactures and sells hemostatic (hemorrhage control) products under the QuikClot Combat Gauze and QuikClot Control+ brand names increasing the market for Hemostats.

Hemostats Market, by Product Type



  • Thrombin based

  • Combination-based

  • Oxidized regenerated cellulose based

  • Gelatin-based

  • Collagen-based hemostat

  • Tissue sealant

  • Fibrin sealants

  • Protein-based sealants

  • Cyanoacrylate-based tissue adhesives

  • Adhesion prevention products


Hemostats Market, by Instrument Type



  • Halstead mosquito hemostatic forceps

  • Kelly and Crile hemostatic forceps

  • Rochester-carmalt hemostatic forceps


Hemostats Market, by Application Type



  • Cardiovascular surgery

  • General surgery

  • Gynecological surgery

  • Reconstructive surgery

  • Neurological surgery

  • Orthopedic surgery

  • Other surgeries


Hemostats Market, by End-Users



  • Hospitals

  • Clinics

  • Ambulatory surgery centers

  • Community healthcare

  • Others


Hemostats Market, by Region



  • Americas

    • North America

    • US

    • Canada

    • South America



  • Europe

    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe

    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Advanced Surgical Trainees

  • Governmental Agency

  • Educational Organizations

  • Medical Device Manufacturers

  • Research Institutes and Academic Centers

  • Market Research and Consulting



Report Scope:

Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   6.4% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Instrument type, Application, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).
  Key Market Opportunities   Rise in the number of hospitals and surgical centers
  Key Market Drivers

  • Growing number of surgical procedures
  • Continuous progression in products range
  • Rising incidences of sports-related damages
  • Spinal disorders
  • Technological advancements
  • Increasing focus on effective blood loss management


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Blood loss occurs in surgeries due to the damage of blood vessels. It is vital to coalesce the blood to avoid too much of blood loss. The formation of blood clots at the site of injury is called hemostasis.

    Hemostats are surgical tools that are used during surgeries to control the bleeding of the patient. These surgical instruments help to temporarily form blood clots to control bleeding. The hemostat is also known as a hemostatic clamp and arterial forceps. It is fundamentally used in the early phases of surgery for a preliminary incision that closes blood vessels till ligation.

    The Hemostats Market is expected to exhibit a strong 6.4% CAGR over the forecast period from 2018 to 2023.

    Growing number of surgical procedures around the world is the major driver for the hemostats market.

    Americas hold the major share in the hemostats market, followed by Europe.

    Leading players in the Hemostats Market include C.R. Bard, Stryker, and Pfizer, among others.